COVID-19 Pediatric Vaccine

expired opportunity(Expired)
From: Federal Government(Federal)
75D30124R72939

Basic Details

started - 11 Apr, 2024 (17 days ago)

Start Date

11 Apr, 2024 (17 days ago)
due - 18 Apr, 2024 (10 days ago)

Due Date

18 Apr, 2024 (10 days ago)
Bid Notification

Type

Bid Notification
75D30124R72939

Identifier

75D30124R72939
HEALTH AND HUMAN SERVICES, DEPARTMENT OF

Customer / Agency

HEALTH AND HUMAN SERVICES, DEPARTMENT OF (26942)CENTERS FOR DISEASE CONTROL AND PREVENTION (3192)CDC OFFICE OF ACQUISITION SERVICES (2781)

Attachments (2)

unlockUnlock the best of InstantMarkets.

Please Sign In to see more out of InstantMarkets such as history, intelligent business alerts and many more.

Don't have an account yet? Create a free account now.

The Centers for Disease Control and Prevention (CDC) is seeking to award one or more indefinite delivery indefinite quantity (IDIQ) contracts for the purchase of standard pediatric vaccines. Item Description and QuantitiesCovid-19 Vaccine - Pediatric (Ages 0-18 years)Maximum ordering quantity: Up to 30 million dosesMinimum ordering quantity: 100 dosesMinimum order size: 100 dosesFederal Excise Tax: $0.75 per doseOrdering period: One year from date of awardThe establishment of these contracts provides an opportunity to utilize VFC funds and Section 317 vaccine purchase funds to obtain vaccines at prices below those available in the commercial marketplace. In addition, awardees may opt to purchase additional quantities of vaccine under any resulting contract to provide immunizations for children who are not federally vaccine- eligible children using state and local funds.Offerors for this requirement must be manufacturers of pediatric vaccines in accordance with 42 U.S.C. § 1396s. The
term "manufacturer" means any corporation, organization, or institution, whether public or private (including Federal, State, and local departments, agencies, and instrumentalities), which manufactures, imports, processes, or distributes under its label any pediatric vaccine. The term "manufacture" means to manufacture, import, process, or distribute a vaccine.Offers shall be submitted by 4:30PM Easter time (EST) on April 17, 2024. Offers shall be submitted electronically (via email) in Microsoft Word and/or Microsoft Excel files to Matthew Nelson, Contract Specialist, lza0@cdc.gov and David Dombeck, Contracting Officer, vwj8@cdc.gov. Offers shall reference RFP No. 75D30124R72939. This acquisition will be conducted in accordance with FAR Part 12, Acquisition of Commercial Items, in conjunction with FAR Part 15. The solicitation and any amendments issued will be posted on www.SAM.gov when issued. No hard copies of the solicitation and amendments will be mailed. Inquiries about the solicitation shall be submitted to Matthew Nelson, Contract Specialist, at lza0@cdc.gov. The deadline for questions to be submitted prior to the due date for proposals is April 12, 2024 at 4:30PM EST. The Government may not answer questions received after this date.
Also Search For

USALocation

Place Of Performance : N/A

Country : United States

Office Address : 1600 CLIFTON ROAD ATLANTA , GA 30333 USA

Country : United StatesState : GeorgiaCity : Atlanta

You may also like

OVER THE COUNTER (OTC) COVID-19 TESTS

Due: 19 Mar, 2025 (in 10 months)Agency: OFFICE OF ASSISTANT SECRETARY FOR PREPAREDNESS AND RESPONSE

EO14042 - VACCINE MANDATE FOR COVID19 INFO - KAPPA LAMBA AND HEVY LITE TESTING KITS

Due: 14 Jun, 2025 (in 13 months)Agency: VETERANS AFFAIRS, DEPARTMENT OF

OVER THE CONTER (OTC) COVID-19 TESTS

Due: 19 Mar, 2025 (in 10 months)Agency: OFFICE OF ASSISTANT SECRETARY FOR PREPAREDNESS AND RESPONSE

Please Sign In to see more like these.

Don't have an account yet? Create a free account now.

Classification

naicsCode 325412Pharmaceutical Preparation Manufacturing
pscCode 6505Drugs and Biologicals